PUMA BIOTECHNOLOGY, INC.
Balance Sheet
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $67.1M | $76.8M | $84.6M | $81.8M | $60.0M | $61.4M | $76.2M | $78.0M |
| Accounts Receivable | $28.1M | $24.6M | $47.8M | $29.0M | $31.3M | $31.2M | $40.4M | $28.0M |
| Inventory | $9.0M | $7.1M | $7.1M | $5.7M | $7.6M | $3.9M | $4.5M | $5.5M |
| Total Current Assets | $137.7M | $143.0M | $156.2M | $125.4M | $118.6M | $111.8M | $134.3M | $122.4M |
| Property, Plant & Equipment | $680.0K | $757.0K | $855.0K | $907.0K | $977.0K | $1.0M | $1.1M | $1.3M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | $60.9M | — | — | — | $70.6M | — |
| Total Assets | $205.0M | $214.1M | $230.5M | $203.6M | $200.5M | $196.3M | $222.1M | $198.8M |
| Liabilities | ||||||||
| Accounts Payable | $13.5M | $9.0M | $6.9M | $5.1M | $7.8M | $8.6M | $6.4M | $14.9M |
| Total Current Liabilities | $104.3M | $98.2M | $99.4M | $67.4M | $60.3M | $48.2M | $77.5M | $60.0M |
| Long-Term Debt | $43.7M | $54.7M | $65.7M | $76.6M | $87.6M | $98.6M | $98.3M | $98.0M |
| Total Liabilities | $156.5M | $163.2M | $177.1M | $164.9M | $170.1M | $170.4M | $200.5M | $176.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.35B | $-1.35B | $-1.35B | $-1.36B | $-1.36B | $-1.37B | $-1.37B | $-1.36B |
| Total Stockholders' Equity | $48.5M | $51.0M | $53.4M | $38.7M | $30.4M | $25.8M | $21.6M | $22.2M |